Erika Sutanto‐Ward
Lankenau Institute for Medical Research(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Tryptophan and brain disorders, Immune cells in cancer, Pancreatic and Hepatic Oncology Research, Virus-based gene therapy research
Most-Cited Works
- → Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy(2005)1,062 cited
- → IDO Is a Nodal Pathogenic Driver of Lung Cancer and Metastasis Development(2012)319 cited
- → A key in vivo antitumor mechanism of action of natural product-based brassinins is inhibition of indoleamine 2,3-dioxygenase(2007)172 cited
- → IDO1 is an Integral Mediator of Inflammatory Neovascularization(2016)89 cited
- → Non-hematopoietic expression of IDO is integrally required for inflammatory tumor promotion(2010)52 cited
- → Host IDO2 Gene Status Influences Tumor Progression and Radiotherapy Response in KRAS -Driven Sporadic Pancreatic Cancers(2018)46 cited
- → Peptide vaccination directed against IDO1-expressing immune cells elicits CD8+ and CD4+ T-cell-mediated antitumor immunity and enhanced anti-PD1 responses(2020)46 cited
- → Bin1 Ablation in Mammary Gland Delays Tissue Remodeling and Drives Cancer Progression(2007)46 cited
- → IDO1 Signaling through GCN2 in a Subpopulation of Gr-1+ Cells Shifts the IFNγ/IL6 Balance to Promote Neovascularization(2021)31 cited
- → Bin3 Deletion Causes Cataracts and Increased Susceptibility to Lymphoma during Aging(2008)30 cited